Literature DB >> 18164515

Upregulation of EMMPRIN after permanent focal cerebral ischemia.

Wei Zhu1, Steve Khachi, Qi Hao, Fanxia Shen, William L Young, Guo-Yuan Yang, Yongmei Chen.   

Abstract

Elevated activities of matrix metalloproteinases (MMPs) following ischemic stroke have been shown to mediate ischemic injury as well as neurovascular remodeling. The extracellular MMP inducer (EMMPRIN) is a 58-kDa cell surface glycoprotein, which has been known to play a key regulatory role for MMP activities. The roles of EMMPRIN in stroke injury are not clearly understood. In this study, we investigated changes of EMMPRIN in a mouse model of permanent focal cerebral ischemia, and examined potential association between EMMPRIN and MMP-9 expression. Adult male CD-1 mice were subjected to permanent focal ischemia by intraluminal occlusion of the left middle cerebral artery (MCAO) under anesthesia. EMMPRIN expression was markedly upregulated in the peri-infarct area at 2-7 days after ischemia compared to the contralateral non-ischemic hemisphere by Western blot analysis. Immunofluorescent double staining demonstrated that EMMPRIN signals co-localized with vwF-positive endothelial cells and GFAP-positive peri-vascular astrocytes. In contrast, EMMPRIN signal did not co-localize with NeuN-positive neurons, or MPO-positive neutrophils. Dual fluorescent staining revealed that EMMPRIN co-localized with MMP-9. Our data also demonstrated that increased EMMPRIN expression correlated with increased MMP-9 levels in a temporal manner. In summary, we report for the first time that EMMPRIN expression was significantly increased in a mouse model of permanent focal cerebral ischemia. The spatial and temporal association between increased EMMPRIN expression and elevated MMP-9 levels suggest that EMMPRIN may modulate MMP-9 activity, and participate in neurovascular remodeling after ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164515      PMCID: PMC2375043          DOI: 10.1016/j.neuint.2007.11.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  25 in total

1.  MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations.

Authors:  Yongmei Chen; Yongfeng Fan; K Y Trudy Poon; Achal S Achrol; Michael T Lawton; Yiqian Zhu; Charles E McCulloch; Tomoki Hashimoto; Chanhung Lee; Nicholas M Barbaro; Andrew W Bollen; Guo-Yuan Yang; William L Young
Journal:  Front Biosci       Date:  2006-09-01

2.  Interleukin-6 involvement in brain arteriovenous malformations.

Authors:  Yongmei Chen; Ludmila Pawlikowska; Jianhua S Yao; Fanxia Shen; Wenwu Zhai; Achal S Achrol; Michael T Lawton; Pui-Yan Kwok; Guo-Yuan Yang; William L Young
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

3.  Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.

Authors:  Yi Tang; Marian T Nakada; Patricia Rafferty; Jenny Laraio; Francis L McCabe; Hillary Millar; Mark Cunningham; Linda A Snyder; Peter Bugelski; Li Yan
Journal:  Mol Cancer Res       Date:  2006-06       Impact factor: 5.852

4.  Role of matrix metalloproteinases in delayed cortical responses after stroke.

Authors:  Bing-Qiao Zhao; Sophia Wang; Hahn-Young Kim; Hannah Storrie; Bruce R Rosen; David J Mooney; Xiaoying Wang; Eng H Lo
Journal:  Nat Med       Date:  2006-03-26       Impact factor: 53.440

Review 5.  EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.

Authors:  Eric E Gabison; Thanh Hoang-Xuan; Alain Mauviel; Suzanne Menashi
Journal:  Biochimie       Date:  2005 Mar-Apr       Impact factor: 4.079

6.  Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.

Authors:  Anna Rosell; Arantxa Ortega-Aznar; José Alvarez-Sabín; Israel Fernández-Cadenas; Marc Ribó; Carlos A Molina; Eng H Lo; Joan Montaner
Journal:  Stroke       Date:  2006-05-11       Impact factor: 7.914

7.  Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.

Authors:  Ben Davidson; Sophya Konstantinovsky; Søren Nielsen; Hiep Phuc Dong; Aasmund Berner; Mogens Vyberg; Reuven Reich
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

8.  Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.

Authors:  Roland Schmidt; Andreas Bültmann; Martin Ungerer; Nader Joghetaei; Ozgür Bülbül; Sven Thieme; Triantafyllos Chavakis; Bryan P Toole; Meinrad Gawaz; Albert Schömig; Andreas E May
Journal:  Circulation       Date:  2006-02-06       Impact factor: 29.690

9.  Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.

Authors:  Livia S Machado; Anna Kozak; Adviye Ergul; David C Hess; Cesario V Borlongan; Susan C Fagan
Journal:  BMC Neurosci       Date:  2006-07-17       Impact factor: 3.288

10.  CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.

Authors:  Ping Zhu; Ning Lu; Zhan-guo Shi; Jun Zhou; Zhen-biao Wu; Yong Yang; Jin Ding; Zhi-nan Chen
Journal:  Arthritis Res Ther       Date:  2006-02-08       Impact factor: 5.156

View more
  12 in total

1.  Hypoxia upregulates CD147 through a combined effect of HIF-1α and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors.

Authors:  Xia Ke; Fei Fei; Yanke Chen; Li Xu; Zheng Zhang; Qichao Huang; Hongxin Zhang; Hushan Yang; Zhinan Chen; Jinliang Xing
Journal:  Carcinogenesis       Date:  2012-06-07       Impact factor: 4.944

2.  EMMPRIN Promotes the Expression of MMP-9 and Exacerbates Neurological Dysfunction in a Mouse Model of Intracerebral Hemorrhage.

Authors:  Yang Liu; Qian Bai; V Wee Yong; Mengzhou Xue
Journal:  Neurochem Res       Date:  2022-05-24       Impact factor: 4.414

3.  Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.

Authors:  Rong Jin; Adam Y Xiao; Rui Chen; D Neil Granger; Guohong Li
Journal:  Stroke       Date:  2017-11-07       Impact factor: 7.914

4.  Increased expression of EMMPRIN and VEGF in the rat brain after gamma irradiation.

Authors:  Ming Wei; Hong Li; Huiling Huang; Desheng Xu; Dashi Zhi; Dong Liu; Yipei Zhang
Journal:  J Korean Med Sci       Date:  2012-02-23       Impact factor: 2.153

5.  Upregulation of EMMPRIN (OX47) in Rat Dorsal Root Ganglion Contributes to the Development of Mechanical Allodynia after Nerve Injury.

Authors:  Qun Wang; Yanyuan Sun; Yingna Ren; Yandong Gao; Li Tian; Yang Liu; Yanan Pu; Xingchun Gou; Yanke Chen; Yan Lu
Journal:  Neural Plast       Date:  2015-11-30       Impact factor: 3.599

Review 6.  Rational modulation of the innate immune system for neuroprotection in ischemic stroke.

Authors:  Diana Amantea; Giuseppe Micieli; Cristina Tassorelli; María I Cuartero; Iván Ballesteros; Michelangelo Certo; María A Moro; Ignacio Lizasoain; Giacinto Bagetta
Journal:  Front Neurosci       Date:  2015-04-29       Impact factor: 4.677

7.  Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.

Authors:  Bao-Qing Xu; Zhi-Guang Fu; Yao Meng; Xiao-Qing Wu; Bo Wu; Liang Xu; Jian-Li Jiang; Ling Li; Zhi-Nan Chen
Journal:  Oncotarget       Date:  2016-09-20

8.  Human tumor cells induce angiogenesis through positive feedback between CD147 and insulin-like growth factor-I.

Authors:  Yanke Chen; Xingchun Gou; Xia Ke; Hongyong Cui; Zhinan Chen
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

9.  Increased CD147 and MMP-9 expression in the normal rat brain after gamma irradiation.

Authors:  Hong Li; Ming Wei; Shenghui Li; Ziwei Zhou; Desheng Xu
Journal:  J Radiat Res       Date:  2012-08-21       Impact factor: 2.724

10.  EMMPRIN/CD147 plays a detrimental role in clinical and experimental ischemic stroke.

Authors:  Anthony Patrizz; Sarah J Doran; Anjali Chauhan; Hilda Ahnstedt; Meaghan Roy-O'Reilly; Yun-Ju Lai; Gillian Weston; Sami Tarabishy; Anita R Patel; Rajkumar Verma; Ilene Staff; Julia K Kofler; Jun Li; Fudong Liu; Rodney M Ritzel; Louise D McCullough
Journal:  Aging (Albany NY)       Date:  2020-03-19       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.